Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2015.25 -4.30 (-0.21%) | NSE 2010.60 -9.50 (-0.47%) | Trade | Add

BSE Live

Dec 26, 16:01

2015.25 -4.30 (-0.21%)

Volume

AVERAGE VOLUME

5-Day

25,939

10-Day

18,470

30-Day

25,126

3,510

Prev. Close

2019.55
Open Price

2043.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 26, 15:55

2010.60 -9.50 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

715,244

10-Day

540,164

30-Day

1,029,643

206,579

Prev. Close

2020.10
Open Price

2018.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Glenmark Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	28.22	28.22	28.22	28.22	28.22
Total Share Capital	28.22	28.22	28.22	28.22	28.22
Reserves and Surplus	6,042.29	5,576.97	5,135.26	4,464.31	3,601.42
Total Reserves and Surplus	6,042.29	5,576.97	5,135.26	4,464.31	3,601.42
Total Shareholders Funds	6,070.51	5,605.18	5,163.48	4,492.53	3,629.64
Minority Interest	-0.39	-0.38	-0.37	-0.42	-0.30
NON-CURRENT LIABILITIES
Long Term Borrowings	4,042.99	3,573.75	4,141.78	4,536.34	2,487.30
Deferred Tax Liabilities [Net]	16.45	6.86	0.00	0.00	0.00
Other Long Term Liabilities	429.27	89.14	2.60	32.74	76.99
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	4,488.71	3,669.75	4,144.38	4,569.08	2,564.29
CURRENT LIABILITIES
Short Term Borrowings	442.60	303.02	295.04	187.19	787.42
Trade Payables	2,125.84	2,220.75	1,869.78	1,743.22	1,940.79
Other Current Liabilities	1,042.34	1,058.97	719.03	534.98	1,207.77
Short Term Provisions	515.20	438.35	404.04	237.29	63.26
Total Current Liabilities	4,125.98	4,021.09	3,287.89	2,702.68	3,999.25
Total Capital And Liabilities	14,684.81	13,295.65	12,595.38	11,763.87	10,192.87
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,977.71	2,097.81	1,895.81	1,783.70	1,643.73
Intangible Assets	1,997.95	1,517.71	1,081.64	923.50	892.34
Capital Work-In-Progress	1,090.64	1,234.37	993.34	629.55	497.83
Fixed Assets	6,197.54	5,014.46	4,099.32	3,415.31	3,078.86
Non-Current Investments	24.59	29.66	14.66	15.69	17.20
Deferred Tax Assets [Net]	1,455.71	1,389.81	1,320.26	1,311.27	1,064.88
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	150.45	110.16	120.34	99.06	70.15
Total Non-Current Assets	7,881.19	6,598.82	5,606.69	4,889.23	4,288.57
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	2,135.62	2,252.07	2,030.59	2,139.05	1,567.76
Trade Receivables	2,408.96	2,194.59	2,331.81	2,404.32	2,492.65
Cash And Cash Equivalents	1,111.24	937.77	1,234.69	1,057.66	857.12
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	1,147.79	1,312.40	1,391.61	1,273.61	986.77
Total Current Assets	6,803.62	6,696.83	6,988.69	6,874.64	5,904.30
Total Assets	14,684.81	13,295.65	12,595.38	11,763.87	10,192.87
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	437.37	239.88	177.62	115.72	143.52
BONUS DETAILS
Bonus Equity Share Capital	15.84	15.84	15.84	15.84	15.84
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.03	0.10	0.00	0.14	0.10
Non-Current Investments Unquoted Book Value	24.56	29.56	14.56	15.56	17.10
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00